What is NDC 70771-1787?

70771-1787 is the product NDC for Scopolamine, Scopolamine 1 mg/3d patch, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Scopolamine?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Scopolamine NDC 70771-1787 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1787Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1787Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1787-2	7077117870270771178702	10 POUCH in 1 CARTON (70771-1787-2) / 1 PATCH in 1 POUCH / 3 d in 1 PATCHMarketed from Sep 5, 2024
70771-1787-4	7077117870470771178704	4 POUCH in 1 CARTON (70771-1787-4) / 1 PATCH in 1 POUCH (70771-1787-1) / 3 d in 1 PATCHMarketed from Sep 5, 2024
70771-1787-7	7077117870770771178707	24 POUCH in 1 CARTON (70771-1787-7) / 1 PATCH in 1 POUCH / 3 d in 1 PATCHMarketed from Sep 5, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Scopolamine
Generic name (nonproprietary): scopolamine
Active ingredients: Scopolamine — 1 mg/3d
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217893
Marketing start: Sep 5, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 70771-1787_2bd0ca3f-183d-4af2-8c0e-962115d97fedSPL ID 2bd0ca3f-183d-4af2-8c0e-962115d97fedSPL set ID 016df9f3-61d5-45e9-b1d6-791a5d2f26d5RxCUI 226552UNII DL48G20X8X
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771178702 followed by a unit qualifier and the quantity

Package 70771-1787-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 23, 2025.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1787

What is NDC 70771-1787?: 70771-1787 is the product NDC for Scopolamine, Scopolamine 1 mg/3d patch, extended release, listed with the FDA by Zydus Lifesciences Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Scopolamine.
What is the active ingredient?: Scopolamine.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Scopolamine?: 13 other product NDCs are listed under this name. See all Scopolamine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Scopolamine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Amneal Pharmaceuticals NY LLC	69238-1662	69238-1662-0269238-1662-0469238-1662-09
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Rhodes Pharmaceuticals LLC	42858-150	42858-0150-1442858-0150-4042858-0150-70
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	71335-3013	71335-3013-01
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	71335-3014	71335-3014-01
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	71335-3015	71335-3015-01
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Bryant Ranch Prepack	72162-2453	72162-2453-0272162-2453-0472162-2453-07
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1846	70710-1846-0270710-1846-0470710-1846-07
scopolamine	Scopolamine 1 mg/3d	SystemTransdermal	Actavis Pharma, Inc.	0591-2258	00591-2258-0400591-2258-2300591-2258-79
scopolamine	Scopolamine 1 mg/3d	SystemTransdermal	A-S Medication Solutions	50090-7188	50090-7188-00
Scopolamine	Scopolamine 1.5 mg/1	Patch, Extended releaseTransdermal	Ingenus Pharmaceuticals, LLC	50742-505	50742-0505-0450742-0505-1050742-0505-24

All 14 Scopolamine NDCs

Other NDCs under ANDA 217893

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217893
Product	Strength	Form · route	Labeler	Product NDC
Scopolamine	Scopolamine 1 mg/3d	Patch, Extended releaseTransdermal	Zydus Pharmaceuticals USA Inc.	70710-1846